Cancer Research · 2018 · 124 citations · 24 references
PharmacyImmunologyOncologyCancer ImmunologyCancer PharmacologyTumor ImmunologyAntibody CharacterizationAntibody FunctionPharmacokinetics Of Monoclonal AntibodiesTherapeutic Antibody DevelopmentAntibodiesAntibody Therapeutic EfficacyAntibody-based RadiotracersBiodistribution StudiesChimeric Monoclonal AntibodiesFc Receptor-mediated MechanismsHumanized Monoclonal AntibodiesMonoclonal Antibody Therapeutics
Abstract A critical benchmark in the development of antibody-based therapeutics is demonstration of efficacy in preclinical mouse models of human disease, many of which rely on immunodeficient mice. However, relatively little is known about how the biology of various immunodeficient strains impacts the in vivo fate of these drugs. Here we used immunoPET radiotracers prepared from humanized, chimeric, and murine mAbs against four therapeutic oncologic targets to interrogate their biodistribution in four different strains of immunodeficient mice bearing lung, prostate, and ovarian cancer xenografts. The immunodeficiency status of the mouse host as well as both the biological origin and glycosylation of the antibody contributed significantly to the anomalous biodistribution of therapeutic monoclonal antibodies in an Fc receptor-dependent manner. These findings may have important implications for the preclinical evaluation of Fc-containing therapeutics and highlight a clear need for biodistribution studies in the early stages of antibody drug development. Significance: Fc/FcγR-mediated immunobiology of the experimental host is a key determinant to preclinical in vivo tumor targeting and efficacy of therapeutic antibodies. Cancer Res; 78(7); 1820–32. ©2018 AACR.
24
Continuous cultures of fused cells secreting antibody of predefined specificity
Georges Köhler, César Milstein · Nature · 1975 · 17.2K citations
Pharmacy, Cell Biology, Immunology +11
Clinical development success rates for investigational drugs
Michael Hay, David W. Thomas, John L. Craighead et al. · Nature Biotechnology · 2014 · 2.5K citations
Leonard D. Shultz, Bonnie Lyons, Lisa Burzenski et al. · The Journal of Immunology · 2005 · 1.7K citations · Full text
Preclinical research: Make mouse studies work
Steve Perrin · Nature · 2014 · 660 citations · Full text